| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | +47.3% | — |
| R&D Expense | $1.4M | +3.3% | -6.5% |
| SG&A Expense | $10.3M | -34.7% | -19.1% |
| Operating Income | -$38.9M | +14.6% | -24.4% |
| Income Tax | $0 | — | — |
| Net Income | -$28.4M | +80.3% | +68.7% |
| EPS (Basic) | -$0.19 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $234.4M | -17.5% | +180.1% |
| Accounts Receivable | $1.6M | -25.0% | — |
| Inventory | $10.7M | -0.3% | +62.0% |
| Current Assets | $265.4M | -15.7% | +161.5% |
| Total Assets | $989.1M | -5.1% | +25.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$114.1M | — | — |
| Capital Expenditures | $27.5M | — | — |
| Investing Cash Flow | -$27.5M | — | — |
| Financing Cash Flow | $347.3M | — | — |
| Free Cash Flow | -$141.6M | — | — |
| +64.8% |
| EPS (Diluted) | -$0.31 | +61.7% | +42.6% |
| $118.4M |
| -19.5% |
| +103.1% |
| Total Liabilities | $621.6M | -4.3% | +13.6% |
| Stockholders' Equity | $68.2M | -31.0% | -71.7% |